BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11081607)

  • 1. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
    Trune DR; Kempton JB; Kessi M
    Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
    Trune DR; Kempton JB; Gross ND
    Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
    Gross ND; Kempton JB; Trune DR
    Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldosterone and prednisolone control of cochlear function in MRL/MpJ-Fas(lpr) autoimmune mice.
    Trune DR; Kempton JB
    Hear Res; 2001 May; 155(1-2):9-20. PubMed ID: 11335072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid treatment improves cochlear function in the MRL.MpJ-Fas(lpr) autoimmune mouse.
    Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
    Hear Res; 1999 Nov; 137(1-2):160-6. PubMed ID: 10545643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid treatment in young MRL.MpJ-Fas(lpr) autoimmune mice prevents cochlear dysfunction.
    Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
    Hear Res; 1999 Nov; 137(1-2):167-73. PubMed ID: 10545644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
    Trune DR; Kempton JB; Harrison AR; Wobig JL
    Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose combination steroids control autoimmune mouse hearing loss.
    Trune DR; Kempton JB
    J Neuroimmunol; 2010 Dec; 229(1-2):140-5. PubMed ID: 20800906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking the glucocorticoid receptor with RU-486 does not prevent glucocorticoid control of autoimmune mouse hearing loss.
    Trune DR; Kempton JB
    Audiol Neurootol; 2009; 14(6):423-31. PubMed ID: 19923812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid-responsive cochlear dysfunction in the MRL/lpr autoimmune mouse.
    Wobig RJ; Kempton Jb; Trune DR
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):344-7. PubMed ID: 10504585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
    Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss.
    Vivero RJ; Joseph DE; Angeli S; He J; Chen S; Eshraghi AA; Balkany TJ; Van de Water TR
    Laryngoscope; 2008 Nov; 118(11):2028-35. PubMed ID: 18818553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining the cause of hearing loss: differential diagnosis using a comparison of audiometric and otoacoustic emission responses.
    Mills DM
    Ear Hear; 2006 Oct; 27(5):508-25. PubMed ID: 16957501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis.
    Worsøe L; Brandt CT; Lund SP; Østergaard C; Thomsen J; Cayé-Thomasen P
    Laryngoscope; 2010 Sep; 120(9):1872-9. PubMed ID: 20717948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of auditory steady-state responses and auditory brainstem responses in audiometric assessment of adults with sensorineural hearing loss.
    Lin YH; Ho HC; Wu HP
    Auris Nasus Larynx; 2009 Apr; 36(2):140-5. PubMed ID: 18620826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase inhibitor facilitates recovery of hearing by protecting the cochlear lateral wall from acute cochlear mitochondrial dysfunction.
    Mizutari K; Matsunaga T; Kamiya K; Fujinami Y; Fujii M; Ogawa K
    J Neurosci Res; 2008 Jan; 86(1):215-22. PubMed ID: 17722114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strial dysfunction in the MRL-Fas mouse.
    Ruckenstein MJ; Milburn M; Hu L
    Otolaryngol Head Neck Surg; 1999 Oct; 121(4):452-6. PubMed ID: 10504603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.